A-LabInsider launched an app to boost biotech businesses Kumar Jeetendra | November 12, 2020 Berlin, Germany – 12 November, 2020 – Life Science Newswire – A-LabInsider has created an application that lists all academic life science labs in Europe with an intelligence to filter through them to make it easier for small and medium biotech companies to discover labs and do business with them. The concept was to create …
Lupin, Concord Biotech get USFDA gesture for generic immunosuppressant cases Kumar Jeetendra | November 12, 2020 New Delhi, Nov 12 (PTI) Drug firm Lupin on Thursday stated that in alliance with Concord Biotech, it has obtained acceptance from the US health regulator to market generic immunosuppressant Tacrolimus capsules used in the Western industry. In cooperation with Concord Biotech, the business has obtained approval from the United States Food and Drug Administration …
Australian COVID-19 immunization:produces antibody response in early tests Kumar Jeetendra | November 13, 2020 Early testing of an expected COVID-19 vaccine developed by an Australian university and CSL has revealed it to be secure and produce an antibody response, Minister for Health Greg Hunt said on Friday. Pharmaceutical companies are rushing to create effective treatments for the illness amid a spike in COVID-19 cases that has killed over a …
Pill Connect secures £0.5m to take electronic smart pill bottle that monitors patient adherence to commercial launch Kumar Jeetendra | November 14, 2020 Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round with the support of the serial entrepreneur Jonathan Milner, Catapult Ventures and Shallcross Partners. The capital raised will enable Pill Connect to complete development of the design, electronics and software for submission to the regulatory authorities in both Europe and the US …
Researchers translate why COVID-19 spares in kids Kumar Jeetendra | November 14, 2020 Researchers have found an integral aspect that might explain why the book coronavirus predominantly affects adults and older individuals while seeming to spare younger kids, an advance that may lead to the development of new treatment strategies for COVID-19. According to the researchers, including those from the Vanderbilt University Medical Center (VUMC) in the united …
Dotmatics collaborates with LabVoice Kumar Jeetendra | November 14, 2020 Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced a new partnership with LabVoice to provide R&D scientists with the ability to record, access, and track data within an electronic laboratory notebook (ELN) using hands-free voice-assisted technology. The …
P3 Reagent Kit Expands Potential of Illumina’s NextSeq 2000 Kumar Jeetendra | November 14, 2020 Illumina, San Diego, has expanded the reach of this NextSeq2000 Sequencing System with the commercial access to the P3 high-output flow cell. The P3 flow cell offers 1.1 billion reads in a single sequencing run, almost 3 times greater than previously accessible on Illumina’s mid-throughput NextSeq sequencing portfolio, expanding the range of applications that run …
Johnson and Johnson, US government extend settlement to help next phase of COVID-19 immunization R&D Kumar Jeetendra | November 15, 2020 Johnson & Johnson and the US Department of Health and Human Services have expanded an agreement to support the next phase of COVID-19 vaccine candidate research and development, the company said on Saturday. Under the agreement the company will commit approximately $604 million and the HHS Department’s Biomedical Advanced Research and Development Authority will commit …
China finds Covid on frozen beef, garbage from different nations Kumar Jeetendra | November 15, 2020 The eastern Chinese city of Jinan said it has discovered that the new coronavirus on beef and tripe, and on packaging for these products, from Brazil, New Zealand and Bolivia as China ramps up testing on frozen foods. The importers were a component of Guotai International Group and Shanghai Zhongli Development Trade, the Jinan Municipal …
Lead Pharma Enters into a Research Collaboration and License Agreement with Roche Kumar Jeetendra | November 16, 2020 OSS, The Netherlands, November 16, 2020 Lead Pharma, a clinical stage pharmaceutical company, designing and developing innovative medicines for the treatment of immune mediated diseases and cancer, today announced that it has entered into a collaboration and license agreement with Roche to develop oral small molecules to treat a broad range of immune mediated diseases. …
Dose-escalation study to evaluate safety, biological and early clinical effect of CALY-002 in healthy volunteers and patients with Celiac Disease and Eosinophilic Esophagitis Kumar Jeetendra | November 16, 2020 AMSTERDAM, The Netherlands, November 16, 2020 Calypso Biotech, a company developing Interleukin-15-targeted biologics, today announced completion of dosing of first cohort of healthy subjects in the first Phase 1 clinical trial of CALY-002, a novel humanized monoclonal antibody neutralizing IL-15. “CALY-002 is the lead program of our differentiated pipeline of IL-15-targeting biologics, that we plan …
Bacteria use signaling particles to adjust their way of life to winning everyday environments Kumar Jeetendra | November 16, 2020 Bacteria are considered to be true experts in survival. Their rapid adaptive response to changing environmental conditions is based, among other things, on two rival signaling molecules. As the”Yin and Yang” of metabolic control they choose the lifestyle of bacteria, according to researchers in the University of Basel. The findings also play a role in …
